Tyra Biosciences (TYRA) CFO Alan Fuhrman Receives Award

What Happened Alan Fuhrman, Chief Financial Officer of Tyra Biosciences (TYRA), acquired 951 shares on 2026-09-15 at a reported price of $9.13 per share, for a total value of $8,682. The transaction is reported as an award/acquisition (code A) and was filed with the SEC on 2026-09-17.

Key Details

• Transaction date and price: 2026-09-15, 951 shares at $9.13 each (total $8,682).
• Filing date: 2026-09-17 — filed two days after the transaction, which is within the typical 2-business-day Form 4 window.
• Shares owned after the transaction: Not specified in the provided filing details.
• Footnotes: F1 — shares acquired under the Issuer's 2021 Employee Stock Purchase Plan (ESPP). F2 — ownership totals include restricted stock units (RSUs).
• Transaction code: A (award/acquisition).

Context This was an acquisition through the company’s Employee Stock Purchase Plan, a standard way employees buy company stock—often seen as a routine employee purchase rather than a market-timing trade. The filing is timely; no late-report indication was provided. As with all insider filings, this confirms ownership change but does not state the insider’s motivations.